| Risk of Prostate Cancer Death in the PLCO Cohort Based on a Four Kallekrein Panel |
Jonathan Shoag |
Case Western Reserve University |
PLCO |
Feb 16, 2022 |
PLCO-912 |
| Machine Learning for Breast Cancer Risk Prediction |
Sigrid Sandström |
Stockholm University |
PLCO |
Feb 16, 2022 |
PLCO-910 |
| An evaluation of the association between aspirin and NSAID use and changes in body mass index on gastrointestinal cancer incidence and mortality |
Holli Loomans-Kropp |
The Ohio State University |
PLCO |
Feb 15, 2022 |
PLCO-907 |
| The Lung EArly Proteins (LEAP) Project |
Hilary Robbins |
International Agency for Research on Cancer |
PLCO |
Feb 3, 2022 |
2021-1022 |
| Competing risks analysis of multiple cancers with application to vitamin D in PLCO |
Yei Eun Shin |
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute |
PLCO |
Feb 2, 2022 |
PLCO-904 |
| Development of a ML algorithm to predict ovarian cancer risk |
Nicolas Martelin |
Prostperia SAS |
PLCO |
Jan 27, 2022 |
PLCO-903 |
| Lung Cancer Patient's survival analysis |
Sreekanth Settur |
Swiss School of Business and Management |
PLCO |
Jan 27, 2022 |
PLCO-902 |
| BMI and the risk of renal cell carcinoma : a case control study |
Benjamin Chung |
Stanford University |
PLCO |
Jan 18, 2022 |
PLCO-896 |
| Radiomic analysis of Chest radiographs for prediction of lung cancer outcomes |
Anant Madabhushi |
Emory University |
PLCO |
Jan 18, 2022 |
PLCOI-887 |
| Interpretable AI prediction of prostate tumor staging |
Matthias Weidemüller |
Universität Heidelberg |
PLCO |
Jan 18, 2022 |
PLCO-897 |
| Threshold quantile regression models with applications to PSA data |
Eun Ryung Lee |
Sungkyunkwan University |
PLCO |
Jan 7, 2022 |
PLCO-893 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
Percy Guzman |
PLCO |
Jan 7, 2022 |
PLCO-882 |
| Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |
| Development of deep learning frameworks based on pathology images for biomarker development |
Jennifer Beane |
Trustees of Boston University |
PLCO |
Jan 5, 2022 |
PLCOI-881 |
| The impact of hormone replacement therapy on cancer |
Zhaoyu Li |
University of Western Australia |
PLCO |
Dec 30, 2021 |
PLCO-883 |
| Meta-analysis of 16S head and neck cancer |
Kenny Yeo |
University of Adelaide |
PLCO |
Dec 14, 2021 |
PLCO-879 |
| Detection of prostate cancer using machine learning techniques: An exploratory study |
Laxmi Manasa Gorugantu |
Dakota State University |
PLCO |
Dec 13, 2021 |
PLCO-873 |
| Reproducibility and external validation of epidemiological risk models for endometrial cancer |
Aline Talhouk |
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada |
PLCO |
Dec 13, 2021 |
PLCO-878 |
| Breast cancer prognosis |
Lee Cooper |
Northwestern University |
PLCO |
Dec 13, 2021 |
PLCOI-877 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification |
Eric Li |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 10, 2021 |
PLCOI-876 |
